Treatment(s) now being considered-Radical prostatectomy - Page 2 of 5 Posts on Medivizor
Navigation Menu

Treatment(s) now being considered-Radical prostatectomy Posts on Medivizor

Does diabetes increase the risk of metastases and castration resistant prostate cancer after a radical prostatectomy?

Posted by on Jun 4, 2019 in Prostate cancer | 0 comments

In a nutshell This article investigated the link between blood glucose control and long-term prostate cancer (PC) outcomes in men with diabetes mellitus (DM) who are having a radical prostatectomy (RP; complete removal of the prostate).  The authors concluded that a worse blood glucose control was associated with metastases and...

Read More

Prostate cancer: can we predict recurrence?

Prostate cancer: can we predict recurrence?

Posted by on May 19, 2019 in Prostate cancer | 0 comments

In a nutshell This study examined the biochemical recurrence (BCR) of prostate cancer after minimally invasive prostate surgery. This study concluded the risk of BCR of prostate cancer decreases as the number of years after surgery without the disease increases.  Some background One treatment option for patients with prostate...

Read More

Local treatment plus androgen deprivation therapy used as treatment for node-positive prostate cancer.

Posted by on Dec 17, 2017 in Prostate cancer | 0 comments

In a nutshell This study aims to find out if local treatment with or without ADT  is useful in the case of node-positive prostate cancer. This study found that local therapy and androgen deprivation therapy (ADT) is more effective for patients with node-positive prostate cancer than ADT alone.    Some background Local treatment or...

Read More

Ability to reach orgasm following prostate surgery

Ability to reach orgasm following prostate surgery

Posted by on Dec 9, 2017 in Prostate cancer | 0 comments

In a nutshell The authors aimed to determine a patient’s ability to reach orgasm after robot-assisted laparoscopic prostatectomy (RALP) based on demographics, cancer-related and surgical variables, and erectile aids. The authors concluded that men could reach orgasm an average of 3 years after RALP. Poor orgasmic ability was associated with men...

Read More

Looking for men with high-risk prostate cancer to test whether apalutamide improves surgery outcomes

Posted by on Dec 5, 2017 in Prostate cancer | 0 comments

In a nutshell The aim of this trial is to determine the effect of the hormone therapy apalutamide (ARN-509) with or without abiraterone acetate (Zytiga), GnRH agonists or prednisone and whether they improve prostate surgery outcomes in men with high-risk prostate cancer. The outcomes to be measured include erectile function, continence, and effect on...

Read More

Partial gland ablation versus prostate surgery in men with low- or intermediate-risk prostate cancer

Partial gland ablation versus prostate surgery in men with low- or intermediate-risk prostate cancer

Posted by on Nov 20, 2017 in Prostate cancer | 0 comments

In a nutshell The authors aimed to determine patient outcomes following partial gland ablation compared to robot-assisted radical prostate surgery in men with low- and intermediate- risk prostate cancer. The authors concluded that men with cancer confined to the prostate benefited from partial gland ablation, as it was more successful with fewer side...

Read More

Comparing the side effects of treatment options for localized prostate cancer

Posted by on Jul 3, 2017 in Prostate cancer | 0 comments

In a nutshell This study aimed to investigate the outcomes and side effects of radical prostatectomy, external beam radiation therapy, and active surveillance in men with localized prostate cancer. This study concluded that radical prostatectomy led to a greater decrease in sexual function and urinary continence compared to the other two treatment...

Read More

Can radiation and hormone therapy after surgery improve prostate cancer survival rates?

Can radiation and hormone therapy after surgery improve prostate cancer survival rates?

Posted by on Jan 21, 2017 in Prostate cancer | 1 comment

In a nutshell The aim of this study was to determine whether radiation therapy in combination with hormonal therapy improved survival in men with prostate cancer that has spread to the lymph nodes after surgery. Researchers concluded that patients treated with radiation therapy and hormone therapy had a significantly higher survival rate compared to...

Read More

Examining surgery as a primary treatment for high-risk prostate cancer

Examining surgery as a primary treatment for high-risk prostate cancer

Posted by on Dec 12, 2016 in Prostate cancer | 0 comments

In a nutshell This study examined evidence for the role of prostate surgery in treating high-risk prostate cancer. Authors concluded that surgery is an effective primary treatment option for men with high-risk disease. Some background Localized prostate cancer is cancer that is confined to the prostate gland. Men with high-risk localized prostate...

Read More